Focused Ultrasound for the Treatment of Neuropathic Pain
Launched by NEUROLOGICAL ASSOCIATES OF WEST LOS ANGELES · Jul 21, 2020
Trial Information
Current as of July 03, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The present open-label study is being undertaken to evaluate focused transcranial ultrasound therapy as an intervention for patients with neuropathic pain. The subjects in this research study will be recruited through medical practice. Participants who are enrolled will undergo 8 consecutive weekly ultrasound sessions. Targeting for treatment will be based on patient MRI scans using stereotaxic techniques.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • History of neuropathic pain (onset, location, intensity, duration, quality, aggravating factors)
- • Confirmation of nervous system injury through imaging or negative or positive sensory signs confined to the corresponding bodily area
- • Failure from at least 3 pharmacological treatments (e.g., antidepressants, anticonvulsants, opioids)
- • At least 18 years of age
- Exclusion Criteria:
- • Subjects unable to give informed consent
- • Subjects who would not be able to lay down without excessive movement in a calm environment
- • Pregnancy, women who may become pregnant or are breastfeeding
- • Subjects with scalp rash or open wounds on the scalp (for example from treatment of squamous cell cancer)
About Neurological Associates Of West Los Angeles
Neurological Associates of West Los Angeles is a leading clinical research organization specializing in the advancement of neurological therapies and treatments. With a commitment to enhancing patient care and outcomes, the organization conducts innovative clinical trials that focus on a range of neurological disorders, including epilepsy, multiple sclerosis, and Alzheimer's disease. Equipped with a team of experienced researchers and state-of-the-art facilities, Neurological Associates fosters collaboration with pharmaceutical companies and academic institutions to bring cutting-edge therapies from the lab to the clinic, ensuring a rigorous and ethical approach to clinical research. Their mission is to contribute to the scientific understanding of neurological conditions while prioritizing patient safety and well-being throughout the research process.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Santa Monica, California, United States
Patients applied
Trial Officials
Sheldon Jordan, MD
Principal Investigator
Neurological Associates of West Los Angeles
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials